Stevanato Group S.p.A.
STVN | NYSE
$19.86
+$0.48 (+2.48%)
Nov 2, 2026, 9:49 AM ET · Market open
Company Profile
Stevanato Group S.p.A. is dedicated to engineering, manufacturing, and distributing integrated solutions for the pharmaceutical and healthcare sectors. Its core offerings span a wide array of products, including containment solutions, drug delivery systems, and medical devices, alongside diagnostic and analytical support. The company also produces specialized machinery for tasks such as visual inspection, assembly, packaging, and glass formation. Established in 1949, the company's main operations are situated in Piombino Dese, Italy, functioning as a subsidiary of Stevanato Holding S.R.L.
Key Executives
| Name | Position |
|---|---|
| Franco Stevanato | Chief Executive Officer & Executive Chairman |
| Marco Dal Lago | Chief Financial Officer |
| Carla Costa | Chief Human Resources Officer |
| Lisa Miles | Chief Communications & Investor Relations Officer |
| Mauro Stocchi | Chief Business Officer |
| Michele Monico | President of DDS & IVD Business Unit |
| Raffaele Pace | President of Engineering Business Unit |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 30, 2026 | 4 | Filing |
| Aug 14, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 13, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Aug 10, 2026 | 4 | Filing |
| Aug 10, 2026 | 4 | Filing |
| Aug 10, 2026 | 4 | Filing |
| Aug 06, 2026 | 6-K | Filing |
| Aug 04, 2026 | 6-K | Filing |
| Aug 04, 2026 | 6-K | Filing |
| Aug 04, 2026 | 6-K | Filing |
Stevanato Group S.p.A.
| Country | Italy |
| IPO Date | Jul 16, 2021 |
| Industry | Medical - Instruments & Supplies |
| Sector | Healthcare |
| Employees | 6,010 |
| CEO | Franco Stevanato |
Contact Details
Via Molinella, 17 Piombino Dese,
PD 35017 Italy
Stock Details
| Ticker Symbol | STVN |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001849853 |
| CUSIP Number | T9224W109 |
| ISIN Number | IT0005452658 |
| SIC Code | 3221 |
Recent News
- 6 days ago / seekingalpha.comConestoga Small Cap Composite Q3 2026 Portfolio Activity
- 6 days ago / businesswire.comStevanato Group and Aptar Pharma Collaborate to Help Accelerate Pre-Filled Syringe System Selection
- 13 days ago / businesswire.comStevanato Group to Report Third Quarter 2026 Financial Results on November 3, 2026
- 2 months ago / seekingalpha.comStevanato Group S.p.A. (STVN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
- 2 months ago / businesswire.comStevanato Group to Participate in Two Upcoming Investor Conferences
- 2 months ago / gurufocus.comA Look at Stevanato Group SpA (STVN) After 3.4% Decline -- GF Value $25.98 vs Price $20.71
- 2 months ago / gurufocus.comStevanato Group SpA (STVN) Shares Fall 5.7% -- What GF Score of 87 Tells Investors
- 3 months ago / zacks.comIs Stevanato (STVN) a Solid Growth Stock? 3 Reasons to Think "Yes"
- 3 months ago / seekingalpha.comStevanato Group S.p.A. (STVN) Q2 2026 Earnings Call Transcript
- 3 months ago / zacks.comStevanato Group (STVN) Q2 Earnings Top Estimates
Add to Watchlist
Select watchlists to add or remove STVN